Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Gallardo

Showing results (151-160 of 229) with videos related to

Pageof 23
Sort By:
The West Indian Medical Journal|March 18, 2015
Budd-Chiari Syndrome in a Patient with JAK-2 V617F and Factor V G1691A MutationsJ S Velarde-Félix, J Sanchez-Zazueta, F P Gonzalez-Ibarra, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1996
Five-day course of granulocyte colony-stimulating factor in patients with prolonged neutropenia after adjuvant chemotherapy for breast cancer is a safe and cost-effective schedule to maintain dose-intensityA Ribas, J Albanell, J Bellmunt, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 9, 2001
Segregation of leading-edge and uropod components into specific lipid rafts during T cell polarizationC Gómez-Móuton, J L Abad, E Mira, et al.
Neurology|June 25, 2010
Redefining dysferlinopathy phenotypes based on clinical findings and muscle imaging studiesC Paradas, J Llauger, J Diaz-Manera, et al.
Blood|March 10, 2001
Urokinase-dependent plasminogen activation is required for efficient skeletal muscle regeneration in vivoF Lluís, J Roma, M Suelves, et al.
Prenatal Diagnosis|October 16, 2002
Prenatal detection of a cystic fibrosis mutation in fetal DNA from maternal plasmaM C González-González, M García-Hoyos, M J Trujillo, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|December 1, 2016
SEOM Clinical Guideline for treatment of muscle-invasive and metastatic urothelial bladder cancer (2016)M Lázaro, E Gallardo, M Doménech, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|January 30, 2013
Phase II trial of sequential subcutaneous interleukin-2 plus interferon alpha followed by sorafenib in renal cell carcinoma (RCC)J P Maroto, X G del Muro, B Mellado, et al.
Scientific Reports|July 13, 2019
The β2-adrenergic receptor antagonist ICI-118,551 blocks the constitutively activated HIF signalling in hemangioblastomas from von Hippel-Lindau diseaseA M Cuesta, V Albiñana, E Gallardo-Vara, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|March 5, 2021
Clinical and molecular characterization of Chilean patients with X-linked hypophosphatemiaM Jiménez, D Ivanovic-Zuvic, C Loureiro, et al.
Pageof 23

Showing results (151-160 of 229) with videos related to

Sort By:
Pageof 23
The West Indian Medical Journal|March 18, 2015
Budd-Chiari Syndrome in a Patient with JAK-2 V617F and Factor V G1691A MutationsJ S Velarde-Félix, J Sanchez-Zazueta, F P Gonzalez-Ibarra, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1996
Five-day course of granulocyte colony-stimulating factor in patients with prolonged neutropenia after adjuvant chemotherapy for breast cancer is a safe and cost-effective schedule to maintain dose-intensityA Ribas, J Albanell, J Bellmunt, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 9, 2001
Segregation of leading-edge and uropod components into specific lipid rafts during T cell polarizationC Gómez-Móuton, J L Abad, E Mira, et al.
Neurology|June 25, 2010
Redefining dysferlinopathy phenotypes based on clinical findings and muscle imaging studiesC Paradas, J Llauger, J Diaz-Manera, et al.
Blood|March 10, 2001
Urokinase-dependent plasminogen activation is required for efficient skeletal muscle regeneration in vivoF Lluís, J Roma, M Suelves, et al.
Prenatal Diagnosis|October 16, 2002
Prenatal detection of a cystic fibrosis mutation in fetal DNA from maternal plasmaM C González-González, M García-Hoyos, M J Trujillo, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|December 1, 2016
SEOM Clinical Guideline for treatment of muscle-invasive and metastatic urothelial bladder cancer (2016)M Lázaro, E Gallardo, M Doménech, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|January 30, 2013
Phase II trial of sequential subcutaneous interleukin-2 plus interferon alpha followed by sorafenib in renal cell carcinoma (RCC)J P Maroto, X G del Muro, B Mellado, et al.
Scientific Reports|July 13, 2019
The β2-adrenergic receptor antagonist ICI-118,551 blocks the constitutively activated HIF signalling in hemangioblastomas from von Hippel-Lindau diseaseA M Cuesta, V Albiñana, E Gallardo-Vara, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|March 5, 2021
Clinical and molecular characterization of Chilean patients with X-linked hypophosphatemiaM Jiménez, D Ivanovic-Zuvic, C Loureiro, et al.
Pageof 23